IBRX

Immunitybio Inc

• PR Newswire·3h ago

  IBRX SHAREHOLDER UPDATE: ImmunityBio (IBRX) Sued After FDA Flags Misleading Cancer Claims, Shares Plunge 21%, $2B Market Cap Lost -- Hagens Berman

• Simply Wall St·1d ago

  ImmunityBio And 2 Insider Picks For Promising Growth

• Reuters·1d ago

  BUZZ-U.S. STOCKS ON THE MOVE-Tyson Foods, Atmus Filtration, Avis Budget

• Benzinga·1d ago

  FDA Flags Anktiva Claims While ImmunityBio Pushes Regulatory Fixes

• Reuters·1d ago

  BUZZ-U.S. STOCKS ON THE MOVE-Legence, Valero Energy, Stereotaxis

• Seeking Alpha·1d ago

  Immunity Bio responds to FDA concerns over Anktiva marketing materials

• TipRanks·1d ago

  ImmunityBio Addresses FDA Warning on ANKTIVA Promotion

• Reuters·1d ago

  BUZZ-ImmunityBio rises after responding to FDA concerns over advertising

• Benzinga·1d ago

  ImmunityBio Submits FDA Response On Ad, Podcast Issues; Co. Tells FDA TV Ad Never Aired, Responds On Podcast

• Reuters·1d ago

  BRIEF-Immunitybio Addresses FDA Correspondence And Reaffirms Commitment To Advertising Compliance

• Reuters·1d ago

  ImmunityBio says FDA-cited TV ad never aired, pulls podcast after OPDP letter

• Simply Wall St·1d ago

  ImmunityBio (IBRX) Is Up 9.6% After FDA Ad Rebuke Collides With Anktiva Trial Progress - What's Changed

• PR Newswire·1d ago

  ImmunityBio, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - IBRX

• TipRanks·3d ago

  ImmunityBio, Keysight, Rubrik, AFLAC, Moody’s Insider Shake-Up

• PR Newswire·3d ago

  INVESTOR NOTICE: ImmunityBio, Inc. (IBRX) Investors with Substantial Losses Have Opportunity to Lead the ImmunityBio Class Action Lawsuit